GlassScriptPhysician profile
Emily Bowers
NPI 1609294727
$10,243.34
in general payments reported to CMS, 2019-2025
20 companies · $1,800 in 2025
The $1,800 reported for 2025 was more than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $317 · 2021: $2,036 · 2022: $1,607 · 2023: $2,466 · 2024: $2,017 · 2025: $1,800.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,279 · Education: $5.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,278.81 |
| Education | $5.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $4,704.00 | 2020-2025 | Rinvoq, Humira, Skyrizi |
| Ucb, INC. | $1,697.47 | 2020-2025 | Cimzia, Bimzelx |
| Astrazeneca Pharmaceuticals LP | $685.67 | 2022-2025 | Saphnelo |
| Amgen INC. | $656.06 | 2020-2025 | Enbrel, Otezla, Enbrel |
| Lilly USA, LLC | $607.54 | 2020-2025 | Taltz |
| Novartis Pharmaceuticals Corporation | $425.72 | 2021-2025 | |
| Janssen Biotech, INC. | $341.90 | 2020-2025 | Tremfya |
| Pfizer INC. | $242.93 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $196.23 | 2020-2025 | Orencia |
| Abbott Laboratories | $163.29 | 2023-2024 | Eterna |
| Glaxosmithkline, LLC. | $139.17 | 2023-2025 | Benlysta, Nucala |
| Janssen Scientific Affairs, LLC | $108.75 | 2025 | Tremfya |
| Organon LLC | $63.82 | 2023-2025 | Hadlima, Renflexis |
| Mallinckrodt Hospital Products INC. | $56.84 | 2020-2023 | Acthar |
| Horizon Therapeutics Plc | $56.48 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $25.96 | 2023 | Actemra |
| Mylan Institutional INC. | $22.80 | 2023 | |
| Radius Health, INC. | $17.69 | 2024 | Tymlos |
| Alexion Pharmaceuticals, INC. | $16.74 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.28 | 2023 | Cyltezo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Bowers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.